FindTrial
Sign In

Changes in Serum cortisol and Blood sugars after intranasal steroid sprays in Allergic Rhinitis

COMPARISON OF ALTERATIONS IN THE LEVELS OF SERUM CORTISOL AND BLOOD SUGARS WITH USAGE OF INTRANASAL MOMETASONE FUROATE AND FLUTICASONE FUROATE IN PATIENTS WITH ALLERGIC RHINITIS - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112212
Enrollment
50
Registered
2026-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Mometasone Furoate and Fluticasone Furoate: 1 puff BD, Intranasal Spray for 2 months Intervention2: Nil: Nil

Sponsors

Sindhoori Butukuri
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cases diagnosed with Allergic Rhinitis Age 18 to 65 years Patients willing to participate Levels of IgE more than 200

Exclusion criteria

Exclusion criteria: Post operative cases of nasal surgeries Patients on immunosuppressive therapy Patients on Radiation or Chemotherapy Known case of Diabetes Mellitus

Design outcomes

Primary

MeasureTime frame
assesment of the changes in serum cortisol and blood sugars levels after intranasal steroid spraysTimepoint: Baseline 8 weeks—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactSindhoori Butukuri

Jawaharlal Nehru Medical College

prashant_patil@yahoo.com9481106368

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026